Latest tumor Stories
LOS ANGELES, Sept.
-- PEG-Irinotecan is a novel, long-acting polymer-drug conjugate which inhibits Topo-I associated with solid tumors SHENYANG, China, Sept.
REDWOOD CITY, Calif., Sept.
Unusually broad range of tumors treated, other benefits seen in first seven months SAN FRANCISCO, Sept.
A study led by University of Colorado Cancer Center published today in the journal Nature uses a novel approach to target the activation of a protein that drives some cancers. AURORA,
ViewRay's MRIdian System Directly Tracks Tumor Motion Continuously During Treatment CLEVELAND, Sept.
SAN ANTONIO, Sept. 9, 2014 /PRNewswire/ -- GenSpera, Inc.
50% of Patients Treated with Mipsagargin had No Tumor Growth at Four Months SAN ANTONIO, Sept. 8, 2014 /PRNewswire/ -- GenSpera, Inc.
Global research initiative to investigate long-term glioblastoma survivors. Chicago, IL (PRWEB) September 03, 2014 The American Brain Tumor Association
- an ornament or knob in the shape of a flower